171 related articles for article (PubMed ID: 11349712)
1. Six-year clinical effect of donor bone marrow infusions in renal transplant patients.
Ciancio G; Miller J; Garcia-Morales RO; Carreno M; Burke GW; Roth D; Kupin W; Tzakis AG; Ricordi C; Rosen A; Fuller L; Esquenazi V
Transplantation; 2001 Apr; 71(7):827-35. PubMed ID: 11349712
[TBL] [Abstract][Full Text] [Related]
2. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.
Garcia-Morales R; Carreno M; Mathew J; Cirocco R; Zucker K; Ciancio G; Burke G; Roth D; Temple D; Fuller L; Esquenazi V; Eskind L; Kenyon NS; Ricordi C; Tzakis A; Miller J
Transplantation; 1998 Apr; 65(7):956-65. PubMed ID: 9565101
[TBL] [Abstract][Full Text] [Related]
3. Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
Ciancio G; Burke GW; Garcia-Morales R; Suzart K; Rosen A; Ricordi C; Kenyon NS; Mathew JM; Tzakis AG; Esquenazi V; Miller J
Transplantation; 2002 Aug; 74(4):488-96. PubMed ID: 12352907
[TBL] [Abstract][Full Text] [Related]
4. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.
Garcia-Morales R; Carreno M; Mathew J; Zucker K; Cirocco R; Ciancio G; Burke G; Roth D; Temple D; Rosen A; Fuller L; Esquenazi V; Karatzas T; Ricordi C; Tzakis A; Miller J
J Clin Invest; 1997 Mar; 99(5):1118-29. PubMed ID: 9062371
[TBL] [Abstract][Full Text] [Related]
5. Donor bone marrow infusion in deceased and living donor renal transplantation.
Ciancio G; Burke GW; Moon J; Garcia-Morales R; Rosen A; Esquenazi V; Mathew J; Jin Y; Miller J
Yonsei Med J; 2004 Dec; 45(6):998-1003. PubMed ID: 15627290
[TBL] [Abstract][Full Text] [Related]
6. Five-year clinical effects of donor bone marrow cells infusions in kidney allograft recipients: improved graft function and higher graft survival.
Solgi G; Gadi V; Paul B; Mytilineos J; Pourmand G; Mehrsai A; Ranjbar M; Mohammadnia M; Nikbin B; Amirzargar AA
Chimerism; 2013; 4(3):87-94. PubMed ID: 23639966
[TBL] [Abstract][Full Text] [Related]
7. Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.
Mathew JM; Garcia-Morales RO; Carreno M; Jin Y; Fuller L; Blomberg B; Cirocco R; Burke GW; Ciancio G; Ricordi C; Esquenazi V; Tzakis AG; Miller J
Transpl Immunol; 2003; 11(3-4):307-21. PubMed ID: 12967784
[TBL] [Abstract][Full Text] [Related]
8. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.
Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Ciancio G; Burke GW; Carreno M; Temple D; Tzakis AG; Ricordi C; Miller J; Esquenazi V
Transplantation; 2000 Dec; 70(12):1675-82. PubMed ID: 11152096
[TBL] [Abstract][Full Text] [Related]
9. [Effect of donor bone marrow transfusion on renal allograft function in kidney transplant patients].
Chen DJ; He Q; Jiang H; Wu JY; Wang YM; Huang HF; Wang HP; Chen JH
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):285-9. PubMed ID: 20544991
[TBL] [Abstract][Full Text] [Related]
10. FoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusion.
Cirocco RE; Carreño MR; Mathew JM; Garcia-Morales RO; Fuller L; Esquenazi V; Ciancio G; Burke GW; Gaynor JJ; Blomberg BB; Rosen A; Kleiner G; Ricordi C; Miller J
Transplantation; 2007 Jun; 83(12):1611-9. PubMed ID: 17589345
[TBL] [Abstract][Full Text] [Related]
11. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
Sarwal MM; Cecka JM; Millan MT; Salvatierra O
Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
[TBL] [Abstract][Full Text] [Related]
12. High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing.
Ricordi C; Karatzas T; Nery J; Webb M; Selvaggi G; Fernandez L; Khan FA; Ruiz P; Schiff E; Olson L; Fernandez H; Bean J; Esquenazi V; Miller J; Tzakis AG
Transplantation; 1997 Jan; 63(1):7-11. PubMed ID: 9000653
[TBL] [Abstract][Full Text] [Related]
13. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
Ciancio G; Burke GW; Suzart K; Roth D; Kupin W; Rosen A; Olson L; Esquenazi V; Miller J
Transplantation; 2002 Apr; 73(7):1100-6. PubMed ID: 11965039
[TBL] [Abstract][Full Text] [Related]
14. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice.
Smith JP; Kasten-Jolly J; Field LJ; Thomas JM
Transplantation; 1994 Aug; 58(3):324-9. PubMed ID: 8053056
[TBL] [Abstract][Full Text] [Related]
15. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.
Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT
Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448
[TBL] [Abstract][Full Text] [Related]
16. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
[TBL] [Abstract][Full Text] [Related]
17. Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays.
Mathew JM; Ciancio G; Burke GW; Garcia-Morales RO; Rosen A; Wang E; Gomez CI; Blomberg BB; Fuller L; Esquenazi V; Ricordi C; Miller J
Hum Immunol; 2010 Jun; 71(6):566-76. PubMed ID: 20153397
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
19. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.
Garcia-Morales R; Esquenazi V; Zucker K; Gomez CI; Fuller L; Carreno M; Cirocco R; Alamo A; Karatzas T; Burke GW; Ciancio G; Temple D; Fernandez H; Ricordi C; Tzakis A; Miller J
Transplantation; 1996 Oct; 62(8):1149-60. PubMed ID: 8900317
[TBL] [Abstract][Full Text] [Related]
20. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
